Literature DB >> 24246752

Indications and outcomes in children receiving renal replacement therapy in pediatric intensive care.

Erin D Boschee1, Dominic A Cave2, Daniel Garros3, Laurance Lequier3, Donald A Granoski3, Gonzalo Garcia Guerra3, Lindsay M Ryerson4.   

Abstract

PURPOSE: We aimed to describe patient characteristics, indications for renal replacement therapy (RRT), and outcomes in children requiring RRT. We hypothesized that fluid overload, not classic blood chemistry indications, would be the most frequent reason for RRT initiation.
MATERIALS AND METHODS: A retrospective cohort study of all patients receiving RRT at a single-center quaternary pediatric intensive care unit between January 2004 and December 2008 was conducted.
RESULTS: Ninety children received RRT. The median age was 7 months (interquartile range, 1-83). Forty-six percent of patients received peritoneal dialysis, and 54% received continuous renal replacement therapy. The median (interquartile range) PRISM-III score was 14 (8-19). Fifty-seven percent had congenital heart disease, and 32% were on extracorporeal life support. The most common clinical condition associated with acute kidney injury was hemodynamic instability (57%; 95% confidence interval [CI], 46-67), followed by multiorgan dysfunction syndrome (17%; 95% CI, 10-26). The most common indication for RRT initiation was fluid overload (77%; 95% CI, 66-86). Seventy-three percent (95% CI, 62-82) of patients survived to hospital discharge.
CONCLUSIONS: Hemodynamic instability and multiorgan dysfunction syndrome are the most common clinical conditions associated with acute kidney injury in our population. In the population studied, the mortality was lower than previously reported in children and much lower than in the adult population.
© 2013.

Entities:  

Keywords:  Acute kidney injury; Pediatric; Peritoneal dialysis; Renal replacement therapy

Mesh:

Year:  2013        PMID: 24246752     DOI: 10.1016/j.jcrc.2013.09.008

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  7 in total

1.  Clinical Features and Indications Associated with Mortality in Continuous Renal Replacement Therapy for Pediatric Patients.

Authors:  Guntulu Sık; Asuman Demirbuga; Seda Günhar; Kemal Nisli; Agop Citak
Journal:  Indian J Pediatr       Date:  2019-02-11       Impact factor: 1.967

2.  Association Between Fluid Balance and Outcomes in Critically Ill Children: A Systematic Review and Meta-analysis.

Authors:  Rashid Alobaidi; Catherine Morgan; Rajit K Basu; Erin Stenson; Robin Featherstone; Sumit R Majumdar; Sean M Bagshaw
Journal:  JAMA Pediatr       Date:  2018-03-01       Impact factor: 16.193

3.  Continuous renal replacement therapy in children: fluid overload does not always predict mortality.

Authors:  Lara de Galasso; Francesco Emma; Stefano Picca; Matteo Di Nardo; Emanuele Rossetti; Isabella Guzzo
Journal:  Pediatr Nephrol       Date:  2015-11-12       Impact factor: 3.714

4.  The effect of continuous venovenous hemodiafiltration on amino acid delivery, clearance, and removal in children.

Authors:  Richard P Lion; Molly R Vega; E O'Brien Smith; Sridevi Devaraj; Michael C Braun; Nathan S Bryan; Moreshwar S Desai; Jorge A Coss-Bu; Talat Alp Ikizler; Ayse Akcan Arikan
Journal:  Pediatr Nephrol       Date:  2021-08-12       Impact factor: 3.714

5.  Outcomes of kidney injury including dialysis and kidney transplantation in pediatric oncology and hematopoietic cell transplant patients.

Authors:  Natalie L Wu; Sangeeta Hingorani
Journal:  Pediatr Nephrol       Date:  2021-01-07       Impact factor: 3.714

6.  Continuous hemofiltration improves the prognosis of bacterial sepsis complicated by liver dysfunction in children.

Authors:  Yun Cui; Xi Xiong; Fei Wang; Yuqian Ren; Chunxia Wang; Yucai Zhang
Journal:  BMC Pediatr       Date:  2018-08-11       Impact factor: 2.125

7.  Pediatric continuous renal replacement therapy: have practice changes changed outcomes? A large single-center ten-year retrospective evaluation.

Authors:  Alyssa A Riley; Mary Watson; Carolyn Smith; Danielle Guffey; Charles G Minard; Helen Currier; Ayse Akcan Arikan
Journal:  BMC Nephrol       Date:  2018-10-19       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.